IHME GBD Cancer Duration for the diagnosis/treatment phase for Acute myeloid leukemia
General Info
Coverage type
Global
Time period covered
January, 1990 - present
Data type
Modeled data
Summary
The duration of the diagnosis/treatment phase for the “Acute myeloid leukemia” group is based on expert opinion on the average length of treatment that patients undergo after the initial diagnosis of AML.
Keywords
Citation
Contributors
Suggested citation
Institute for Health Metrics and Evaluation (IHME). IHME GBD Cancer Duration for the diagnosis/treatment phase for Acute myeloid leukemia.